Biocryst Pharmaceuticals (BCRX.MX) Q4 2023 Earnings

26FebConfirmed
Q4 2023
-5.3
-4.93
-4.57
-4.2

Details

Expected EPS
-4.1998434156
Actual EPS
-5.295327
Surprise EPS
-1.1
Surprise Percent
+26.08%

Description

Biocryst Pharmaceuticals (BCRX.MX) has reported earnings of -5.295327 per share for Q4 2023.

0 Comments

Share your thoughts